ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors

Malignant brain tumors, including gliomas, brain metastases and anaplastic meningiomas, are associated with poor prognosis, and represent an unmet medical need. ASA404 (DMXAA), a vascular disrupting agent, has demonstrated promising results in several preclinical tumor models and early phase clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Bähr, Oliver, Gross, Stefanie, Harter, Patrick N., Kirches, Elmar, Mawrin, Christian, Steinbach, Joachim P., Mittelbronn, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652230/
https://www.ncbi.nlm.nih.gov/pubmed/29098034
http://dx.doi.org/10.3892/ol.2017.6832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652230/
https://www.ncbi.nlm.nih.gov/pubmed/29098034
http://dx.doi.org/10.3892/ol.2017.6832

Ejemplares similares